Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA (original) (raw)

Abstract

Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (21)

  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of cardiology (ESC). endorsed by: association for European paediatric and congenital cardiology (AEPC). Eur Heart J 2015;36:2793-867.
  2. Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc 2009;84:289-97.
  3. Timothy M, Markman DAM, Liang JJ. Catheter ablation for ventricular tachycardia in patients with structural heart disease. US Cardiol Rev 2018;12:51-6.
  4. Palaniswamy C, Kolte D, Harikrishnan P, et al. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm 2014;11:2056-63.
  5. European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American heart association Task force and the European Society of cardiology Committee for practice guidelines (writing Committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol 2006;48:e247-346.
  6. Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008;118:2773-82.
  7. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016;375:111-21.
  8. Kuck K-H, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.
  9. 9 Mukherjee RK, O'Neill L, O'Neill MD. Prophylactic catheter ablation for ventricular tachycardia: are we there yet? Arrhythm Electrophysiol Rev 2017;6:125-8.
  10. Ladapo JA, David G, Gunnarsson CL, et al. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol 2012;23:1-8.
  11. Cheung JW, Yeo I, Ip JE, et al. Outcomes, costs, and 30-day readmissions after catheter ablation of myocardial Infarct- Associated ventricular tachycardia in the real world: nationwide readmissions database 2010 to 2015. Circ Arrhythm Electrophysiol 2018;11:e006754.
  12. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
  13. Briceño DF, Gupta T, Romero J, et al. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: a propensity score- matched analysis of in-hospital outcomes in the United States. J Cardiovasc Electrophysiol 2018;29:771-9.
  14. Zeppenfeld K. Ventricular tachycardia ablation in nonischemic cardiomyopathy. JACC Clin Electrophysiol 2018;4:1123-40.
  15. Dinov B, Fiedler L, Schönbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective heart centre of Leipzig VT (HELP-VT) study. Circulation 2014;129:728-36.
  16. Della Bella P, Trevisi N. Catheter ablation of ventricular tachycardia in nonischemic dilated cardiomyopathy: a difficult field where we should focus our efforts. Circ Arrhythm Electrophysiol 2016;9.
  17. Peichl P, Wichterle D, Pavlu L, et al. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol 2014;7:684-90.
  18. Yousuf OK, Zusterzeel R, Sanders W, et al. Trends and outcomes of catheter ablation for ventricular tachycardia in a community cohort. JACC Clin Electrophysiol 2018;4:1189-99.
  19. Müssigbrodt A, Grothoff M, Dinov B, et al. Irrigated tip catheters for radiofrequency ablation in ventricular tachycardia. Biomed Res Int 2015;2015:389294.
  20. Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-Term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: Post-Approval THERMOCOOL VT trial. J Am Coll Cardiol 2016;67:674-83.
  21. on December 5, 2021 by guest. Protected by copyright. http://openheart.bmj.com/ Open Heart: first published as 10.1136/openhrt-2020-001247 on 30 September 2020. Downloaded from